Strata Critical Medical 2026: Revenue $74.08M, EPS ($0.09) — 10-Q Summary

What happened

Strata Critical Medical reported 2026 quarterly revenue of $74.08 million, up from $49.3 million a year earlier. Net income shifted to a loss of $7.62 million from income of $57.42 million, and diluted EPS was a loss of $0.09 versus earnings of $0.7.

Confirmed

Global impact / market context

Revenue rose sharply, but the company swung to a loss, so sales gains did not translate into profit. That gap suggests higher costs or weaker profit per sale, which matters because investors judge whether growth is self-funding or needs outside cash.

Analyst inference

Nine-month revenue rose 64.1% on logistics growth and clinical services after the Keystone and 2026 acquisitions. Quarterly logistics revenue fell 3.5% on shorter trips. Management cited flattened donor supply, aircraft capacity and clinician hiring as growth constraints.

Analyst inference

What to watch

1. Watch whether logistics revenue recovers, since quarterly logistics revenue declined 3.5% amid shorter trips even as nine-month revenue rose 64.1% on logistics growth. Confirmed
2. Watch whether management secures aircraft capacity and hires and retains clinicians, the two growth conditions it named alongside flattened donor supply. Proposed
3. Watch whether acquired clinical services lift profit, since revenue rose while net income turned to a $7.62 million loss, showing costs may be outpacing sales. Analyst inference

Evidence

• Original source link unavailable